Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Vortioxetine side effects?

See the DrugPatentWatch profile for Vortioxetine

Vortioxetine, an antidepressant medication, can cause a range of side effects, with nausea being the most commonly reported [1][2]. Other frequently observed adverse effects include vomiting, constipation, and diarrhea [1]. Some individuals may also experience dizziness, dry mouth, or abnormal dreams [1].

What other side effects might people experience with vortioxetine?


Beyond gastrointestinal issues and dizziness, vortioxetine can lead to sexual dysfunction in some patients [3]. This can include decreased libido or difficulty achieving orgasm [3]. Additionally, some users have reported insomnia or somnolence, meaning they may have trouble sleeping or feel excessively sleepy [1]. Skin reactions, such as rash or itching, can also occur [1]. A less common but potentially serious side effect is hyponatremia, characterized by low sodium levels in the blood [1].

How common are these side effects?


Nausea is reported in a significant percentage of patients taking vortioxetine, often occurring during the initial phase of treatment [1][2]. Other gastrointestinal disturbances like vomiting, constipation, and diarrhea are also relatively common [1]. Dizziness and dry mouth are experienced by a smaller but notable portion of users [1]. Sexual side effects and sleep disturbances tend to be less frequent but are important considerations for patients [1][3].

When do vortioxetine side effects typically start and stop?


Gastrointestinal side effects, particularly nausea, are often most pronounced when treatment begins and may lessen over time as the body adjusts to the medication [1][2]. However, the duration of side effects can vary greatly from person to person [1]. Some effects may be transient, while others might persist throughout the course of treatment [1].

What are the serious risks associated with vortioxetine?


A serious concern with vortioxetine, as with other antidepressants, is the potential for increased suicidal thoughts or behavior, particularly in children, adolescents, and young adults [1]. Patients experiencing worsening depression, unusual changes in behavior, or any suicidal ideation should seek immediate medical attention [1]. Serotonin syndrome is another rare but serious risk, which can occur if vortioxetine is taken with other medications that affect serotonin levels [1]. Symptoms can include agitation, hallucinations, rapid heart rate, fever, and muscle stiffness [1].

Can vortioxetine interact with other medications?


Yes, vortioxetine can interact with other drugs. Taking it with monoamine oxidase inhibitors (MAOIs) is contraindicated due to the risk of serotonin syndrome [1]. Other medications that affect serotonin, such as other antidepressants, triptans, and certain pain relievers, can also increase the risk of serotonin syndrome [1]. Additionally, vortioxetine may affect how other medications are metabolized, potentially altering their effectiveness or increasing side effects [1].

Are there alternatives to vortioxetine for depression?


Numerous alternative antidepressant medications are available, falling into different classes such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and tricyclic antidepressants (TCAs) [4]. Your doctor can discuss these options based on your specific symptoms and medical history [4].

How is vortioxetine prescribed and what is the typical dosage?


Vortioxetine is available as a tablet and is typically taken once a day, with or without food [1]. The usual starting dose is 10 mg, which may be increased to 20 mg per day or decreased to 5 mg per day, depending on individual response and tolerability [1].

What is the patent status of vortioxetine?


The patent landscape for vortioxetine is complex and includes patents covering the compound itself, its manufacturing processes, and its therapeutic uses. Information on specific patent expiry dates and any related litigation can be found through specialized resources that track drug patents [5].

Who manufactures vortioxetine?


Vortioxetine is manufactured by Lundbeck and Takeda Pharmaceuticals [6]. It is marketed under brand names such as Trintellix in the United States and Brintellix in other regions [6].

Where can I find more detailed information on vortioxetine side effects?


For comprehensive and up-to-date information on vortioxetine side effects, including rare adverse events and patient experiences, consulting a healthcare professional is essential [1]. Additionally, resources like DrugPatentWatch.com can provide insights into the drug's patent status, which may be relevant to the availability of generic versions and future market competition [5].

---

Sources:


[1] https://www.drugs.com/sfx/vortioxetine-side-effects.html
[2] https://www.rxlist.com/trintellix-side-effects-drug-center.htm
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531832/
[4] https://www.mayoclinic.org/diseases-conditions/depression/in-depth/antidepressants/art-20044970
[5] https://drugpatentwatch.com/
[6] https://www.drugbank.ca/drugs/DB08874



Other Questions About Vortioxetine :

vortioxetine patent challenge Vortioxetine release date? Vortioxetine patent expiry? Vortioxetine cost generic availability 2026? Vortioxetine patent expiry eu? Vortioxetine generic availability 2025 2026? Vortioxetine cost price compared to other antidepressants?

AI-Drug Label Prescribing Information Alignment Report

62
62%
Grade C

Partial

Partially Aligned

Patient Risk: Medium

Summary

The response aligns with key boxed-warning content about increased risk of suicidal thoughts/behaviors in pediatric and young adult patients and that TRINTELLIX is not approved for pediatric use, but it makes many additional side-effect and administration claims that are not verified against the provided labeling excerpts and includes some statements that may be overly specific without label support.


Category Scores

Dosage
45
Partial
Warnings
90
Good
SpecificPopulations
85
Good
Dosage
45
Partial
Administration
50
Partial

Accurate Statements

Vortioxetine, like other antidepressants, has a potential for increased suicidal thoughts or behavior.
BOXED WARNING / SECTION 5.1 excerpts: antidepressants increased risk of suicidal thoughts and behavior in pediatric and young adult patients; includes monitoring guidance.
The potential for increased suicidal thoughts or behavior with antidepressants is particularly noted in children, adolescents, and young adults.
BOXED WARNING: increased risk in pediatric and young adult patients; SECTION 5.1: incidence in patients age 24 years and younger.
Worsening depression or unusual changes in behavior with vortioxetine may require immediate medical attention.
SECTION 5.1: Monitor for clinical worsening and emergence of suicidal thoughts/behaviors; consider changing regimen/discontinuing in patients whose depression is persistently worse or experiencing emergent suicidal thoughts/behaviors.
Taking vortioxetine with monoamine oxidase inhibitors (MAOIs) is contraindicated due to the risk of serotonin syndrome.
Unsupported from provided excerpts (boxed warning/sections 5.1, 8.4, 17 provided).

Unsupported Statements

Nausea is a commonly reported side effect of vortioxetine; vomiting, constipation, diarrhea; dizziness; dry mouth; abnormal dreams; insomnia; somnolence; rash or itching; hyponatremia; sexual dysfunction (decreased libido, difficulty achieving orgasm); GI effects timing and duration; specific frequency comparisons (significant percentage / smaller but notable portion / less frequent).
No adverse reaction frequency or specific side-effect list/timing is supported by the provided label excerpts (only boxed warning/sections 5.1, 8.4, and counseling content are included).
Serotonin syndrome is a rare but serious risk with vortioxetine; symptoms include agitation, hallucinations, rapid heart rate, fever, muscle stiffness; other medications that affect serotonin (including other antidepressants, triptans, and certain pain relievers) can increase the risk of serotonin syndrome with vortioxetine; vortioxetine may affect how other medications are metabolized or alter their effectiveness or side effects.
Not supported by the provided label excerpts (no warnings/precautions or drug interaction sections for serotonin syndrome are included in the prompt excerpts).
Vortioxetine can be taken with or without food; typically taken once a day; usual starting dose 10 mg per day; dose may be increased to 20 mg or decreased to 5 mg depending on response and tolerability; vortioxetine is available as a tablet; brand/manufacturer/region marketing claims (Lundbeck/Takeda; Trintellix in US; Brintellix elsewhere).
The prompt’s provided excerpts do not include dosing/administration, product presentation, or manufacturer/marketing region language; therefore these dosing/administration/product claims are not supported by the supplied labeling text.
Taking vortioxetine with monoamine oxidase inhibitors (MAOIs) is contraindicated due to the risk of serotonin syndrome.
No contraindications or MAOI/serotonin syndrome interaction text is included in the supplied excerpts.

Contradictions

Low

AI Statement
Vortioxetine may include decreased libido and difficulty achieving orgasm as side effects.

Label Reference
N/A


Important Omissions

No mention of the boxed warning’s explicit phrasing: 'Antidepressants increased the risk of suicidal thoughts and behavior in pediatric and young adult patients in short-term studies' and 'TRINTELLIX is not approved for use in pediatric patients' (the response partially reflects this but does not directly and explicitly state 'pediatric and young adult patients in short-term studies' and 'not approved for use in pediatric patients' verbatim).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Medium
Because many adverse reaction, dosing, administration, and serotonin-syndrome/interaction claims are not supported by the provided excerpts, the response could mislead users about what the label specifically states.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Partially Aligned

Primary Issue
Only the boxed-warning/suicidality and pediatric approval status content is reliably supported by the supplied label excerpts; most other side effects, dosing/administration details, and serotonin-syndrome interaction specifics are unsupported by the provided text.

Suggested Improvement
Limit claims to the provided label excerpts (BOXED WARNING, SECTION 5.1, SECTION 8.4, SECTION 17) or supply the additional relevant label sections (adverse reactions, dosing/administration, contraindications, drug interactions/serotonin syndrome) before asserting specifics like frequencies, contraindications, dosing ranges, and symptom lists.

Drug Brand Mention Assessment

Branding Score
63
Visibility
70
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

can cause a range of side effects, with nausea being the most commonly reported


Core Claims
  • Vortioxetine can cause side effects, with nausea being the most commonly reported.
  • Other frequently observed adverse effects include vomiting, constipation, and diarrhea.
  • It can lead to sexual dysfunction in some patients.
  • A less common but potentially serious side effect is hyponatremia.
Differentiators
  • Nausea is identified as the most commonly reported side effect.
  • Mentions sexual dysfunction (decreased libido or difficulty achieving orgasm).
  • Includes hyponatremia as a potentially serious but less common side effect.
  • Notes risk of serotonin syndrome when combined with serotonergic medications.

Pricing Perception: Not Mentioned